A citation-based method for searching scientific literature

Kennichi C Dowdell, Lesley Pesnicak, Victoria Hoffmann, Kenneth Steadman, Alan T Remaley, Jeffrey I Cohen, Stephen E Straus, V Koneti Rao. Exp Hematol 2009
Times Cited: 40







List of co-cited articles
416 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.
R Watanabe-Fukunaga, C I Brannan, N G Copeland, N A Jenkins, S Nagata. Nature 1992
20

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.
F Rieux-Laucat, F Le Deist, C Hivroz, I A Roberts, K M Debatin, A Fischer, J P de Villartay. Science 1995
17

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen.
C J Phiel, F Zhang, E Y Huang, M G Guenther, M A Lazar, P S Klein. J Biol Chem 2001
17

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
M C Sneller, J Wang, J K Dale, W Strober, L A Middelton, Y Choi, T A Fleisher, M S Lim, E S Jaffe, J M Puck,[...]. Blood 1997
269
15

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
S E Straus, E S Jaffe, J M Puck, J K Dale, K B Elkon, A Rösen-Wolff, A M Peters, M C Sneller, C W Hallahan, J Wang,[...]. Blood 2001
307
15

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
G H Fisher, F J Rosenberg, S E Straus, J K Dale, L A Middleton, A Y Lin, W Strober, M J Lenardo, J M Puck. Cell 1995
15

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.
M C Sneller, S E Straus, E S Jaffe, J S Jaffe, T A Fleisher, M Stetler-Stevenson, W Strober. J Clin Invest 1992
232
15

Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis.
Sandra J Saouaf, Bin Li, Geng Zhang, Yuan Shen, Narumi Furuuchi, Wayne W Hancock, Mark I Greene. Exp Mol Pathol 2009
97
15

Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection.
Thierry Roger, Jérôme Lugrin, Didier Le Roy, Geneviève Goy, Matteo Mombelli, Thibaud Koessler, Xavier C Ding, Anne-Laure Chanson, Marlies Knaup Reymond, Isabelle Miconnet,[...]. Blood 2011
235
15

Deacetylase inhibition promotes the generation and function of regulatory T cells.
Ran Tao, Edwin F de Zoeten, Engin Ozkaynak, Chunxia Chen, Liqing Wang, Paige M Porrett, Bin Li, Laurence A Turka, Eric N Olson, Mark I Greene,[...]. Nat Med 2007
653
15

Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.
Sandra Camelo, Antonio H Iglesias, Daehee Hwang, Brice Due, Hoon Ryu, Karen Smith, Steven G Gray, Jaime Imitola, German Duran, Basel Assaf,[...]. J Neuroimmunol 2005
219
15

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells.
M Göttlicher, S Minucci, P Zhu, O H Krämer, A Schimpf, S Giavara, J P Sleeman, F Lo Coco, C Nervi, P G Pelicci,[...]. EMBO J 2001
15

An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.
S E Straus, M Sneller, M J Lenardo, J M Puck, W Strober. Ann Intern Med 1999
230
12

Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).
David T Teachey, Dana A Obzut, Kelly Axsom, John K Choi, Kelly C Goldsmith, Junior Hall, Jessica Hulitt, Catherine S Manno, John M Maris, Nicholas Rhodin,[...]. Blood 2006
62
12

Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice.
Pierre Bobé, Danielle Bonardelle, Karim Benihoud, Paule Opolon, Mounira K Chelbi-Alix. Blood 2006
71
12

Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.
V Koneti Rao, Faith Dugan, Janet K Dale, Joie Davis, Jean Tretler, John K Hurley, Thomas Fleisher, Jennifer Puck, Stephen E Straus. Br J Haematol 2005
77
12

Autoimmune lymphoproliferative syndrome with somatic Fas mutations.
Eliska Holzelova, Cédric Vonarbourg, Marie-Claude Stolzenberg, Peter D Arkwright, Françoise Selz, Anne-Marie Prieur, Stéphane Blanche, Jirina Bartunkova, Etienne Vilmer, Alain Fischer,[...]. N Engl J Med 2004
195
12

Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity.
Alessio Nencioni, Julia Beck, Daniela Werth, Frank Grünebach, Franco Patrone, Alberto Ballestrero, Peter Brossart. Clin Cancer Res 2007
120
12


Histone deacetylase inhibitors: overview and perspectives.
Milos Dokmanovic, Cathy Clarke, Paul A Marks. Mol Cancer Res 2007
829
12

Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.
Clayton A White, Egest J Pone, Tonika Lam, Connie Tat, Ken L Hayama, Guideng Li, Hong Zan, Paolo Casali. J Immunol 2014
73
12

Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndrome.
V Koneti Rao, Kennichi C Dowdell, Janet K Dale, Faith Dugan, Lesley Pesnicak, Lilia L Bi, Victoria Hoffmann, Scott Penzak, Nilo A Avila, Thomas A Fleisher,[...]. Am J Hematol 2007
12
33

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
C E Jackson, R E Fischer, A P Hsu, S M Anderson, Y Choi, J Wang, J K Dale, T A Fleisher, L A Middelton, M C Sneller,[...]. Am J Hum Genet 1999
162
10

Targeting Notch signaling in autoimmune and lymphoproliferative disease.
David T Teachey, Alix E Seif, Valerie I Brown, Marlo Bruno, Ralph M Bunte, Yueh J Chang, John K Choi, Jonathan D Fish, Junior Hall, Gregor S Reid,[...]. Blood 2008
62
10

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
T Takahashi, M Tanaka, C I Brannan, N A Jenkins, N G Copeland, T Suda, S Nagata. Cell 1994
10

NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
João B Oliveira, Nicolas Bidère, Julie E Niemela, Lixin Zheng, Keiko Sakai, Cynthia P Nix, Robert L Danner, Jennifer Barb, Peter J Munson, Jennifer M Puck,[...]. Proc Natl Acad Sci U S A 2007
149
10

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.
Hyung J Chun, Lixin Zheng, Manzoor Ahmad, Jin Wang, Christina K Speirs, Richard M Siegel, Janet K Dale, Jennifer Puck, Joie Davis, Craig G Hall,[...]. Nature 2002
501
10

Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome.
David T Teachey, Robert Greiner, Alix Seif, Edward Attiyeh, Jack Bleesing, John Choi, Catherine Manno, Eric Rappaport, Dirk Schwabe, Cecilia Sheen,[...]. Br J Haematol 2009
108
10

Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice.
Pavan Reddy, Yaping Sun, Tomomi Toubai, Raimon Duran-Struuck, Shawn G Clouthier, Elizabeth Weisiger, Yoshinobu Maeda, Isao Tawara, Oleg Krijanovski, Erin Gatza,[...]. J Clin Invest 2008
217
10

Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function.
Jennifer L Brogdon, Yongyao Xu, Susanne J Szabo, Shaojian An, Francis Buxton, Dalia Cohen, Qian Huang. Blood 2007
185
10

Anticancer activities of histone deacetylase inhibitors.
Jessica E Bolden, Melissa J Peart, Ricky W Johnstone. Nat Rev Drug Discov 2006
10

Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition.
Benjamin A Garcia, Scott A Busby, Jeffrey Shabanowitz, Donald F Hunt, Nilamadhab Mishra. J Proteome Res 2005
96
10

The language of covalent histone modifications.
B D Strahl, C D Allis. Nature 2000
10

14-3-3 adaptor proteins recruit AID to 5'-AGCT-3'-rich switch regions for class switch recombination.
Zhenming Xu, Zsolt Fulop, Guikai Wu, Egest J Pone, Jinsong Zhang, Thach Mai, Lisa M Thomas, Ahmed Al-Qahtani, Clayton A White, Seok-Rae Park,[...]. Nat Struct Mol Biol 2010
104
10

HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation.
Seok-Rae Park, Hong Zan, Zsuzsanna Pal, Jinsong Zhang, Ahmed Al-Qahtani, Egest J Pone, Zhenming Xu, Thach Mai, Paolo Casali. Nat Immunol 2009
103
10

Epigenetics of the antibody response.
Guideng Li, Hong Zan, Zhenming Xu, Paolo Casali. Trends Immunol 2013
56
10

MicroRNAs in lupus.
Hong Zan, Connie Tat, Paolo Casali. Autoimmunity 2014
54
10

Regulation of Aicda expression and AID activity.
Hong Zan, Paolo Casali. Autoimmunity 2013
79
10

Immunoglobulin class-switch DNA recombination: induction, targeting and beyond.
Zhenming Xu, Hong Zan, Egest J Pone, Thach Mai, Paolo Casali. Nat Rev Immunol 2012
257
10


Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival.
J J Bleesing, S E Straus, T A Fleisher. Pediatr Clin North Am 2000
61
7

A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome.
Jack J H Bleesing, Margaret R Brown, Cynthia Novicio, David Guarraia, Janet K Dale, Stephen E Straus, Thomas A Fleisher. Clin Immunol 2002
57
7

Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome.
Bridget T Heelan, Vincent Tormey, Peter Amlot, Elspeth Payne, Atul Mehta, A David B Webster. Br J Haematol 2002
24
12

Reversion of autoimmune lymphoproliferative syndrome with an antimalarial drug: preliminary results of a clinical cohort study and molecular observations.
Jutte van der Werff Ten Bosch, Peter Schotte, Alice Ferster, Nadira Azzi, Thomas Boehler, Geneviève Laurey, Mikko Arola, Christian Demanet, Rudi Beyaert, Kris Thielemans,[...]. Br J Haematol 2002
31
9


Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
J J Bleesing, M R Brown, S E Straus, J K Dale, R M Siegel, M Johnson, M J Lenardo, J M Puck, T A Fleisher. Blood 2001
93
7

Pathological findings in human autoimmune lymphoproliferative syndrome.
M S Lim, S E Straus, J K Dale, T A Fleisher, M Stetler-Stevenson, W Strober, M C Sneller, J M Puck, M J Lenardo, K S Elenitoba-Johnson,[...]. Am J Pathol 1998
146
7

Autoimmune lymphoproliferative syndrome.
Michael C Sneller, Janet K Dale, Stephen E Straus. Curr Opin Rheumatol 2003
63
7


Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS).
V Koneti Rao, Susan Price, Katie Perkins, Patricia Aldridge, Jean Tretler, Joie Davis, Janet K Dale, Fred Gill, Kip R Hartman, Linda C Stork,[...]. Pediatr Blood Cancer 2009
57
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.